Ooma Schedules Fourth Quarter & Fiscal Year 2020 Results
SUNNYVALE, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Ooma, Inc. (NYSE: OOMA), a smart communications platform for businesses and consumers, […]
Arco Platform Limited to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 16, 2020
SÃO PAULO, Brazil, Feb. 07, 2020 (GLOBE NEWSWIRE) — Arco Platform Limited, or Arco (Nasdaq: ARCE), today announced that it […]
EuroDry Ltd. Sets Date for the Release of Fourth Quarter 2019 Results, Conference Call and Webcast
MAROUSSI, ATHENS, Greece, Feb. 07, 2020 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY) (the “Company”), an owner and operator of […]
vTv Therapeutics to Host Investor Call and Announce Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 – Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes
HIGH POINT, N.C., Feb. 07, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that it will release the […]
WW Schedules Fourth Quarter and Full Year 2019 Earnings Conference Call
NEW YORK, Feb. 07, 2020 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) will release its results for the fourth […]
Adaptimmune Therapeutics plc Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional American Depositary Shares
PHILADELPHIA, Pa. and OXFORD, United Kingdom, Feb. 07, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader […]
Fancamp closes the second tranche of a non-Brokered private placement flow-through financing
VANCOUVER, British Columbia, Feb. 07, 2020 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Company”) (TSXV: FNC) is pleased […]
Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development
MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality […]
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (NASDAQ:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering […]
Micron Technology to Report Fiscal Second Quarter Results on March 25, 2020
BOISE, Idaho, Feb. 07, 2020 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its […]
